ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

نویسندگان

  • Yuichiro Ohe
  • Christoph Zielinski
چکیده

Correspondence to Dr Yuichiro Ohe; yohe@ ncc. go. jp ESMO Open was launched in January 2016. Since its launch, there have been 199 submissions which have reached a final decision. Due to this impressive acceptance within the community of oncologists, ESMO Open was listed in PubMedCentral within a remarkably short time after the appearance of the first paper (less than 10 months). Apart from important reviews of clinical relevance, many original papers were submitted out of which 15—corresponding to 9% of all publications—were coming from authors from Japan showing and proving the high interest of Japanese Society of Medical Oncology (JSMO) to play an important role within the publication efforts exerted by the European Society for Medical Oncology (ESMO). Thus, it was only logical resulting in our pleasure to announce that JSMO has now decided to associate itself with ESMO Open complementing the former associations of the journal with various other scientific societies including the Associazione Italiana di Oncologia Medica (AIOM), the Chinese Society of Clinical Oncology (CSCO) and the Korean Association for Clinical Oncology (KACO). JSMO is an important society with over 9300 members comprising mainly of medical oncologists, but also of surgeons, radiation oncologists and professionals in other fields of oncology. More than 6000 people attend the annual JSMO meeting, with approximately 10% of free abstracts coming from abroad. Since the establishment of JSMO in 2002, JSMO has had a tight collaboration with ESMO including the adoption of the ESMO/ ASCO core curriculum, joint symposiums during ESMO and JSMO meetings, and an association with Annals of Oncology. Working as a partner of ESMO Open, JSMO will further increase and widen this interaction within the frame of global activities of both JSMO and ESMO. For all of these reasons, JSMO is warmly welcomed by ESMO Open as an associated partner and we hope for a bright future within this very context.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.

The most recent version of the European Society for Medical Oncology (ESMO) consensus guidelines for the treatment of patients with metastatic colorectal cancer (mCRC) was published in 2016, identifying both a more strategic approach to the administration of the available systemic therapy choices, and a greater emphasis on the use of ablative techniques, including surgery. At the 2016 ESMO Asia...

متن کامل

Highlights for ESMO 40: celebration review for lifetime achievement awards

Correspondence to Dr Nagahiro Saijo; [email protected] SUMMARY My work, my crucial achievement, has been in the management of the transition of the conduct of cancer research/management from basic researchers/surgeons to medical oncologists (figure 1). This transition can be divided into four categories: 1. The development, progression and consolidation of global Medical Oncology in Asian countr...

متن کامل

Survey of the management of chemotherapy-induced peripheral neuropathy in Japan: Japanese Society of Medical Oncology

BACKGROUND Various drugs are administered for the management of chemotherapy-induced peripheral neuropathy (CIPN) in Japan. However, there have been no surveys undertaken to identify these drugs or their frequency of prescription. Therefore, we administered a questionnaire survey to the diplomates of the Subspecialty Board of Japanese Society of Medical Oncology (JSMO) to investigate the freque...

متن کامل

CSCO joins ESMO Open—Cancer Horizons

Correspondence to Dr Christoph C Zielinski; christoph.zielinski@ meduniwien.ac.at ESMO Open—Cancer Horizons is happy to announce its association with the Chinese Society of Clinical Oncology (CSCO). After intensive personal contacts between the CSCO President Professor Y-LW and the leadership of the European Society for Medical Oncology (ESMO) as well as the Editor-in-Chief of ESMO Open—Cancer ...

متن کامل

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology

Diagnosis and treatment of bone metastasis requires various types of measures, specialists and caregivers. To provide better diagnosis and treatment, a multidisciplinary team approach is required. The members of this multidisciplinary team include doctors of primary cancers, radiologists, pathologists, orthopaedists, radiotherapists, clinical oncologists, palliative caregivers, rehabilitation d...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 2  شماره 

صفحات  -

تاریخ انتشار 2017